CEO out after damning sales probe

 Posted 31 October 2025 PM

The spectacular fall from grace for Organon boss Kevin Ali who stepped down from the CEO role over improper sales practices was our top story this week.

Ali walked away with no severance or equity-related retirement benefits after an internal investigation revealed the company, under his stewardship, asked certain wholesalers to buy more of the company's birth control implant than they needed over multiple quarters to enable Organon to meet guidance expectations.